ENTRY       D03665                      Drug
NAME        Decitabine (USAN/INN);
            Dacogen (TN)
PRODUCT     DACOGEN (Otsuka America Pharmaceutical)
            DECITABINE (Sun Pharmaceutical Industries)
  GENERIC   DECITABINE (Accord Healthcare)
            DECITABINE (Amneal Pharmaceuticals LLC)
            DECITABINE (Athenex Pharmaceutical Division)
            DECITABINE (BluePoint Laboratories)
            DECITABINE (BluePoint Laboratories)
            DECITABINE (Cipla USA)
            DECITABINE (Dr. Reddy's Laboratories)
            DECITABINE (Dr. Reddy's Laboratories)
            DECITABINE (Dr.Reddy's Laboratories Limited)
            DECITABINE (Eugia US LLC)
            DECITABINE (Fresenius Kabi USA)
            DECITABINE (Gland Pharma Limited)
            DECITABINE (Hikma Pharmaceuticals USA)
            DECITABINE (Ingenus Pharmaceuticals)
            DECITABINE (Lupin Pharmaceuticals)
            DECITABINE (MSN LABORATORIES PRIVATE LIMITED)
            DECITABINE (Meitheal Pharmaceuticals)
            DECITABINE (Mylan Institutional LLC)
            DECITABINE (Nivagen Pharmaceuticals)
            DECITABINE (Northstar Rx LLC)
            DECITABINE (Novadoz Pharmaceuticals LLC)
            DECITABINE (Novadoz Pharmaceuticals LLC)
            DECITABINE (Qilu Pharmaceutical)
            DECITABINE (Sagent Pharmaceuticals)
            DECITABINE (Wockhardt USA LLC.)
            DECITABINE (Zydus Lifesciences Limited)
            DECITABINE (Zydus Pharmaceuticals USA)
FORMULA     C8H12N4O4
EXACT_MASS  228.0859
MOL_WEIGHT  228.2053
CLASS       Antineoplastic
             DG02018  Antimetabolite
              DG01958  Nucleic acid derivative, antineoplastic
               DG01439  Arabinofuranosyl type antineoplastic
REMARK      ATC code: L01BC08
            Product: D03665<US>
            Product (mixture): D11848<US>
EFFICACY    Antineoplastic, Antimetabolite
  DISEASE   Myelodysplastic syndromes [DS:H01481]
COMMENT     Cytidine [CPD:C00475] analog
TARGET      DNMT [HSA:1786 1788 1789] [KO:K00558 K17398 K17399]
  PATHWAY   hsa00270(1786+1788+1789)  Cysteine and methionine metabolism
            hsa05206(1786+1788+1789)  MicroRNAs in cancer
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01B ANTIMETABOLITES
                L01BC Pyrimidine analogues
                 L01BC08 Decitabine
                  D03665  Decitabine (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antimetabolites
               Decitabine
                D03665  Decitabine (USAN/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG02018  Antimetabolite
               DG01958  Nucleic acid derivative, antineoplastic
                DG01439  Arabinofuranosyl type antineoplastic
                 D03665  Decitabine
            Drug classes [BR:br08332]
             Antineoplastic
              DG02018  Antimetabolite
               D03665  Decitabine
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               Methyltransferases
                DNMT
                 D03665  Decitabine (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03665
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03665
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03665
DBLINKS     CAS: 2353-33-5
            PubChem: 17397761
            LigandBox: D03665
            NIKKAJI: J91.053H
ATOM        16
            1   C1y C    27.5800  -21.1400
            2   C1x C    28.9800  -21.1400
            3   C1y C    29.4000  -19.8100
            4   O2x O    28.2800  -18.9700
            5   C1y C    27.1600  -19.8100
            6   C1b C    25.8300  -19.3900
            7   O1a O    26.7400  -22.2600
            8   O1a O    24.7800  -20.3000
            9   N4y N    30.7330  -19.3820
            10  C8y C    31.9454  -20.0820
            11  N5x N    33.1578  -19.3820
            12  C8y C    33.1578  -17.9820
            13  N5x N    31.9454  -17.2820
            14  C8x C    30.7330  -17.9820
            15  O5x O    31.9455  -21.4898
            16  N1a N    34.3832  -17.2743
BOND        17
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     5   6 1 #Up
            7     1   7 1 #Down
            8     6   8 1
            9     3   9 1 #Up
            10    9  10 1
            11   10  11 1
            12   11  12 2
            13   12  13 1
            14   13  14 2
            15    9  14 1
            16   10  15 2
            17   12  16 1
///
